4.6 Article

A Screen for Enhancers of Clearance Identifies Huntingtin as a Heat Shock Protein 90 (Hsp90) Client Protein

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count

Andreas Weiss et al.

ANALYTICAL BIOCHEMISTRY (2011)

Review Medicine, Research & Experimental

Oligonucleotide therapeutic approaches for Huntington disease

Dinah W. Y. Sah et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Medicine, Research & Experimental

Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease

John Labbadia et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Clinical Neurology

Huntington's disease: from molecular pathogenesis to clinical treatment

Christopher A. Ross et al.

LANCET NEUROLOGY (2011)

Review Biochemical Research Methods

Hsp70 and Its Molecular Role in Nervous System Diseases

Giuseppina Turturici et al.

BIOCHEMISTRY RESEARCH INTERNATIONAL (2011)

Article Biochemistry & Molecular Biology

Co-chaperones are limiting in a depleted chaperone network

Lonneke Heldens et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2010)

Article Biochemistry & Molecular Biology

Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle

Gregor P. Lotz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Review Neurosciences

Heat shock protein 90 in neurodegenerative diseases

Wenjie Luo et al.

MOLECULAR NEURODEGENERATION (2010)

Review Cell Biology

HSP90 at the hub of protein homeostasis: emerging mechanistic insights

Mikko Taipale et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)

Article Biochemical Research Methods

Single-step detection of mutant huntingtin in animal and human tissues: A bioassay for Huntington's disease

Andreas Weiss et al.

ANALYTICAL BIOCHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Development of a Method for the High-Throughput Quantification of Cellular Proteins

Paolo Paganetti et al.

CHEMBIOCHEM (2009)

Review Pharmacology & Pharmacy

Small molecule drug discovery for Huntington's Disease

Wolfgang Fecke et al.

DRUG DISCOVERY TODAY (2009)

Article Chemistry, Medicinal

4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer

Paul A. Brough et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Multidisciplinary Sciences

The ground state of embryonic stem cell self-renewal

Qi-Long Ying et al.

NATURE (2008)

Article Multidisciplinary Sciences

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

Jodi L. McBride et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits

M. DiFiglia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Multidisciplinary Sciences

Global changes to the ubiquitin system in Huntington's disease

Eric J. Bennett et al.

NATURE (2007)

Article Neurosciences

Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease

Jesse M. Hunter et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2007)

Article Biochemistry & Molecular Biology

17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration

M Waza et al.

NATURE MEDICINE (2005)

Review Medicine, Research & Experimental

Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery

WB Pratt et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2003)

Article Neurosciences

Neuronal cells show regulatory differences in the hsp70 gene response

K Kaarniranta et al.

MOLECULAR BRAIN RESEARCH (2002)

Article Biochemistry & Molecular Biology

Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice

CJ Cummings et al.

HUMAN MOLECULAR GENETICS (2001)

Article Biochemistry & Molecular Biology

Neurological abnormalities in a knock-in mouse model of Huntington's disease

CH Lin et al.

HUMAN MOLECULAR GENETICS (2001)

Article Multidisciplinary Sciences

Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

PJ Muchowski et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)